The global Iliac stent market size is expected to reach USD 1,708.54 Million by 2032, according to a new study by Polaris Market Research. The report “Iliac Stent Market Share, Size, Trends, Industry Analysis Report, By Type (Self-expandable Stents, Balloon-expandable Stents, Others); By Artery lesions; By End-use, By Region, And Segment Forecasts, 2024-2032” gives a detailed insight into current market dynamics and provides analysis on future market growth.
Several stents are used during iliac stent surgeries for the treatment of iliac arterial lesions and aneurysms. According to studies, stents such as the EPIC stent have shown superior clinical outcomes than others when it comes to managing iliac arterial lesions. The self-expanding EPIC stent is a promising alternative for iliac artery procedures due to its flexibility, improved healing, and decreased neointimal hyperplasia.
In addition, iliac artery aneurysms are treated using percutaneous stent-graft implantation, which offers a replacement for open surgery graft insertion. Stent grafts are implanted during this minimally invasive treatment to treat iliac aneurysms, providing a less invasive method than conventional surgical reconstruction.
Do you have any questions? Would you like to request a sample or make an inquiry before purchasing this report? Simply click the link below:https://www.polarismarketresearch.com/industry-analysis/iliac-stent-market/request-for-sample
In the common iliac artery, the DISCOVER research has clarified the differences among covered and uncovered balloon-expandable stents, highlighting the potential of PTFE-covered stents to lower restenosis rates and enhance clinical outcomes following endovascular therapy. Further supporting the benefits of primary stent implantation above balloon angioplasty for full iliac artery occlusions are the results of the STAG study, which show that stent intervention is associated with a higher rate of technical success and a lower rate of significant procedural problems.
For instance, in May 2022, to assess the safety & effectiveness of iCover for treating aorto-iliac athero-sclerotic lesions in patients with the arteriopathy in the lower limbs, the iliCo study, supervised by iVascular, started its first trial with the drug.
Iliac Stent Market Report Highlights
Polaris Market Research has segmented the Iliac Stent market report based on type, artery lesions, end use, and region:
Iliac Stent, Type Outlook (Revenue - USD Million, 2019 - 2032)
Iliac Stent, Artery Lesions Outlook (Revenue - USD Million, 2019 - 2032)
Iliac Stent, End Use Outlook (Revenue - USD Million, 2019 - 2032)
Iliac Stent, Regional Outlook (Revenue - USD Million, 2019 - 2032)
Report Attributes |
Details |
Market size value in 2024 |
USD 1,101.56 million |
Revenue forecast in 2032 |
USD 1,708.54 million |
CAGR |
5.6% from 2024 – 2032 |
Base year |
2023 |
Historical data |
2019 – 2022 |
Forecast period |
2024 – 2032 |
Quantitative units |
Revenue in USD million and CAGR from 2024 to 2032 |
Segments covered |
|
Regional scope |
|
Competitive Landscape |
|
Report Format |
|
Customization |
Report customization as per your requirements with respect to countries, region, and segmentation. |
For Specific Research Requirements |